Switch to:

Nymox Pharmaceutical EV-to-Revenue

: 557.89 (As of Today)
View and export this data going back to 1997. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Nymox Pharmaceutical's enterprise value is $98.75 Mil. Nymox Pharmaceutical's Revenue for the trailing twelve months (TTM) ended in Mar. 2019 was $0.18 Mil. Therefore, Nymox Pharmaceutical's EV-to-Revenue for today is 557.89.

NAS:NYMX' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.2   Max: 1343.5
Current: 557.78

4.2
1343.5

During the past 13 years, the highest EV-to-Revenue of Nymox Pharmaceutical was 1343.50. The lowest was 4.20. And the median was 208.40.

NAS:NYMX's EV-to-Revenue is ranked lower than
94% of the 809 Companies
in the Biotechnology industry.

( Industry Median: 12.11 vs. NAS:NYMX: 557.78 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, Nymox Pharmaceutical's stock price is $1.62. Nymox Pharmaceutical's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2019 was $0.00. Therefore, Nymox Pharmaceutical's PS Ratio for today is 810.00.


Nymox Pharmaceutical EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Nymox Pharmaceutical Annual Data

Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.03 50.78 456.36 830.51 253.68

Nymox Pharmaceutical Quarterly Data

Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 820.92 529.38 385.72 253.68 682.42

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Nymox Pharmaceutical EV-to-Revenue Distribution

* The bar in red indicates where Nymox Pharmaceutical's EV-to-Revenue falls into.



Nymox Pharmaceutical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Nymox Pharmaceutical's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=98.747/0.177
=557.89

Nymox Pharmaceutical's current Enterprise Value is $98.75 Mil.
Nymox Pharmaceutical's Revenue for the trailing twelve months (TTM) ended in Mar. 2019 was 0.088 (Jun. 2018 ) + 0.04 (Sep. 2018 ) + 0.019 (Dec. 2018 ) + 0.03 (Mar. 2019 ) = $0.18 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Nymox Pharmaceutical  (NAS:NYMX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Nymox Pharmaceutical's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.62/0.002
=810.00

Nymox Pharmaceutical's share price for today is $1.62.
Nymox Pharmaceutical's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2019 was 0.001 (Jun. 2018 ) + 0.001 (Sep. 2018 ) + 0 (Dec. 2018 ) + 0 (Mar. 2019 ) = $0.00.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Nymox Pharmaceutical EV-to-Revenue Explanation


Nymox Pharmaceutical EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}